Extended-spectrum β-lactamases in Klebsiella pneumoniae isolated in a pediatric Hospital of Córdoba, Argentina;β-Lactamasas de espectro extendido en Klebsiella pneumoniae aisladas en el Hospital de Niños de Córdoba, Argentina

Revista Argentina de Microbiologia

Volumn 35, Issue 1, 2003, Pages 1-7

  Saka, H A ^a,b   Egea, M ^a   Culasso, C ^a   Rollan, R ^b   Avaro, A ^a   Carvajal, L ^a  

^a Hospital de Ninos de la Santisima Trinidad   (Argentina)

^b UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

Author keywords

Antimicrobial resistance; Extended spectrum lactamases; Klebsiella pneumoniae; Pediatric infections; Third generation cephalosporins

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME ISOLATION; ESCHERICHIA COLI; HOSPITAL PATIENT; ISOELECTRIC POINT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; PHENOTYPE;

ANTI-BACTERIAL AGENTS; ARGENTINA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CHILD; CONJUGATION, GENETIC; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, PEDIATRIC; HUMANS; ISOELECTRIC POINT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDIES; SUBSTRATE SPECIFICITY;

EID: 0038485947     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. PER-2' wich encodes an extended spectrum class A β-lactamase. Antimicrob. Agents Che-mother. 40: 616-620.
2. Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM (1996) Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2, and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob. Agents Chemother. 40: 509-513.
3. Bradford P (2001) Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-951.
4. Branger C, Lesimple AL, Bruneu B, Berry P, Lambert-Zechovsky N (1998) Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum b-lactamases in a university hospital. J. Med. Microbiol. 47: 209-210.
5. Bush K (2001) New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32: 1085-1089.
6. Bush K, Sykes B (1986) Methodology for the study of β-lactamases. Antimicrob. Agents Chemoter. 30: 6-10.
7. Casellas JM, Goldberg M, Morosini MI, Negri MC, Arduino S, Catalano M, et al (1990) Estudio sobre cepas productoras de β-lactamasas plasmidicas de espectro extendido en Argentina. Infectol. Microbiol. Clin. 2: 14-36.
8. Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ, et al (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multirresistant Acinetobacter baumannii. J. Clin. Microbiol. 38: 4086-4095.
9. Danel F, Hall LM, Duke B, Gur D, Livermore D (1999) OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: 1362-1366.
10. Danel F, Hall LM, Gur D, Livermore D (1995) OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39: 1881-1884.
11. Danel F, Hall LM, Gur D, Livermore D (1998) OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates. Antimicrob. Agents Chemother. 42: 3117-3122.
12. De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J, the French Study Group (2000) A 1998 survey of extended spectrum β-lactamases in Enterobacteriaceae in France. Antimicrob. Agents Chemother. 44: 3177-3179.
13. Fernandez-Rodriguez A, Reguera JA, Perez-Diaz JC, Picazo JJ, Baquero F (1992) 1st Spanish epidemic of plasmid resistance to 3d generation cephalosporins: the implication of SHV-2. Enferm. Infecc. Microbiol. Clin. 10(8): 456-61.
14. Galas M, Rapoport M, Pasterán F, Melano R, Petroni A, Ceriana P, WHONET Argentina collaborative group and Rossi A (1999) High distribution of CTX-M-2 β-lactamase among Klebsiella spp. isolated in an Argentinean extended spectrum b-lactamase (ESBLA) surveillance program. 39th Intersci. Conf. Antimicrob. Agents Chemother. Abstract 149.C2, p. 165, San Francisco, Estados Unidos de America.
15. Galas M, Pasterán F, Melano R, Petroni A, Lopez G, Corso A, Rossi A, the WHONET Collaborative Group (1998) Unusual distribution of enzymatic resistance to third generation cephalosporin (TGC) in E coliin Argentina. 38th Intersci. Conf. Antimicrob. Agents Chemother. Abstract E-109, p. 201, San Diego, Estados Unidos de América.
16. Galas M, Petroni A, Melano R, Corso A, Rodríguez M, Cacace ML, et al (1998) Plasmidic extended-spectrum β-lactamases in Vibrio cholerae O1 El Tor in Argentina. 38th Intersci. Conf. Antimicrob. Agents Chemother. Abstract C-174, p. 119, San Diego, Estados Unidos de América.
17. Jacoby GA, Medeiros AA (1991) More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35: 1697-1704.
18. Jean SS, Teng LJ, Hsueh PR, Ho SW, Luh KT (2002) Antimicrobial susceptibility among clinical isolates of extended-spectrum cephalosporin-resistant Gram negative bacteria in a Taiwanese University Hospital. J. Antimicrob. Chemoter. 49: 69-76.
19. Kim J, Kwon Y, Pai H, Kim JW, Cho DT (1998) Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol. 36: 1446-1449.
20. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Widemann B (1985) Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28: 302-307.
21. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S (1983) Transferible resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11: 315-317.
22. Labia R, Barthélémy M (1979) L'enzymogramme des beta-lactamases: adaptation en gel de la methode iodometrique. Ann. Microbiol. (Paris) 130B:295-304.
23. Livermore DM (1995) β-lactamases in laboratory and clinical resistance. Clin Microbiol. Rev. 8: 557-584.
24. Livermore DM, Williams JD (1996) β-lactams: Mode of action and mechanisms of bacterial resistance. En: Lorian V (Ed), Antibiotics in laboratory medicine, Fourth Edition, MD Edition, Baltimore, p. 503-578.
25. Livermore DM (1996) β-lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemoter. 41: 25-41.
26. Marchese A, Arlet G, Schito GC, Lagrange PH, Philippon A (1996) Detection of SHV-5 extended-spectrum β-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur. J. Clin. Microbiol. Infect. Dis. 15: 245-247.
27. Medeiros, AA (1997) Evolution and dissemination of β-lactamases accelerated by generation of β-lactam antibiotics. Clin. Infect. Dis. 24 (Suppl 1): 19-45.
28. Millar MR, Walsh TR, Linton CJ, Zhang S, Leeming JP, Bennett PM, the ALSPAC Study Team (2001) Carriage of antibiotic-resistant bacteria by healthy children. J. Antimicrob. Chemoter. 47: 605-610.
29. National Committee for Clinical Laboratory Standards (2000) Performance standards for antimicrobial disk susceptibility test, Seventh Edition, Approved standard, Document M2-A7, Wayne, Pennsylvania, Estados Unidos de América.
30. National Committee for Clinical Laboratory Standards (2000) Methods for dilution susceptibility tests for bacteria that grow aerobically, Fifth Edition, Approved standard, Document M7-A5, Wayne, Pennsylvania, Estados Unidos de América.
31. National Committee for Clinical Laboratory Standards (2001) Performance standards for antimicrobial susceptibility testing, eleventh informational supplement, Document M100-S11, Wayne, Pennsylvania, Estados Unidos de América.
32. Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R (1993) Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37: 962-969.
33. Nüesch-Inderbinen MT, Kayser FH, Hächier H (1997) Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceaein Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimcrob. Agents Chemother. 41: 943-949.
34. th International Congress on Infectious Diseases. Abstract 13.010, p. 24, Buenos Aires, Argentina.
35. Pal H, Lyu S, Lee JH, Kim J, Kwon Y, Kim JW, Choe KW (1999) Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J. Clin. Microbiol. 37: 1758-1763.
36. Pasteran F, Melano R, Galas M, Rodríguez M, WHONET- Argentina collaborative group and Rossi A (1999) High proportion of extended-spectrum β-lactamases among AMP-C producers enterobacteria in Argentina. 39th Intersci. Conf. Antimicrob. Agents Chemother. Abstract 149.C2, p. 166, San Francisco, Estados Unidos de América.
37. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossen H, Von Gottberg et al (2000) Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamases production in Klebsiella pneumoniae isolates causing bacteriemia. Clin. Infect. Dis. 30: 473-478.
38. Petroni A, Corso A, Melano R, Cacace M L, Bru A M, Rossi A, Galas, M (2002) Plasmidic extended-spectrum β-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina. Antimicrob. Agents Chemoter. 46: 1462-1468.
39. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev., 11: 589-603.
40. Power, P, Radice M, Barberis C, de Mier C, Mollerach M, Maltagliatti M, et al (1999) Cefotaxime-hydrolysing beta-lactamases in Morganella morganii. Eur. J. Clin. Microbiol. Infect. Dis. 18: 743-747.
41. Radice, M, González C, Power P, Vidal M del C, Gutkind G (2001) Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg. Infect. Dis. 7: 442-443.
42. Radice, M, Power P, Di Conza J, Gutkind G (2002) Early Dissemination of CTX-M-derived enzymes in South America. Antimicrob. Agents Chemoter. 46: 602-604.
43. Rice BR, Bonomo RA (1996) Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents. En: Lorian V (Ed), Antibiotics in laboratory medicine, Fourth Edition, MD Editor, Baltimore, p. 483-484.
44. Rice LB, Ecskstein S, De Vente J, Shlaes DM (1996) Ceftazidime resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin. Infect. Dis. 23: 118-124.
45. Rossi, A, Galas M, Binsztein N, Rivas M, Caffer MI, Corso A, et al (1993) Unusual multiresistant Vibrio cholerae O1 El Tor in Argentina. Lancet 342: 1172-1173.
46. Rossi A, Galas M, Tokumoto M, Guelfand L, Lopardo H, Grupo colaborativo WHONET-Argentina (1999) Actividad in vitro de trovafloxacina, otras fluoroquinolonas y de diferentes antimicrobianos frente a aislamientos clínicos. Medicina (Buenos Aires) 59 (Supl. I): 8-16.
47. Rossi, A, Lopardo H, Woloj M, Picandet AM, Marifio M, Galas M, et al (1995) Non-typhoid Salmonella spp. resistant to cefotaxime. J. Antimicrob. Chemother. 36: 697-702.
48. Sanders CC, Sanders Jr. WE, Moland ES (1986) Characterization of β-lactamases in situ on polyacrilamide gels. Antimicrob. Agents Chemoter. 30: 951-952.
49. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF (1999) Detection and reporting of organisms producing extended-spectrum β-lactamases: survey of laboratories in Connecticut. J. Clin. Microbiol. 37: 4065-4070.
50. Vahaboglu H, Öztürk R, Aygün G, Coskunkan F, Yaman A, Kaygusuz A, et al (1997) Widespread detection of PER-1 type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41: 2265-2269.
51. Vecoli C, Prevost FE, Ververis JJ, Medeiros AA, O'Leary Jr. GP (1983) Comparison of poliacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of β-lactamases. Antimicrob. Agents Chemoter. 24: 186-189.
52. Vila J, Navia M, Ruiz J, Casals C (1997) Cloning and nucleotide sequence analysis of gene encoding an OXA-derived β-lactamase in Acinatobacter baumannii, Antimicrob. Agents Chemother. 41: 2757-2759.